Private Trust CO Na Akero Therapeutics, Inc. Transaction History

Private Trust CO Na

$938 Million
Q1 2025

A detailed history of Private Trust CO Na transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Private Trust CO Na holds 112 shares of AKRO stock, worth $5,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112

Holding current value

$5,398

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 Apr 28, 2025	BUY	$21.87 - $57.56 $2,449 - $6,446	112 New	112 $4,000
Q3 2023 Oct 18, 2023	BUY	$41.19 - $52.25 $2,512 - $3,187	61 New	61 $3,000

Others Institutions Holding AKRO

# of Institutions

270

Shares Held

86M

Call Options Held

1.02M

Put Options Held

823K

Rtw Investments, LP New York, NY

7.42M
Shares

$358 Million
4.92% of portfolio
Janus Henderson Group PLC London, X0

7.07M
Shares

$341 Million
0.16% of portfolio
Wellington Management Group LLP Boston, MA

5.94M
Shares

$286 Million
0.05% of portfolio
Black Rock Inc. New York, NY

5.59M
Shares

$269 Million
0.0% of portfolio
General Atlantic LLC New York, NY

5.23M
Shares

$252 Million
7.15% of portfolio

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.24B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.

Account